Changyong Wei

Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin

Sevim Dalva-Aydemir, Richa Bajpai, Maylyn Martinez et al. · Clinical Cancer Research · 2014 · 139 citations · Full text

Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion

Rachel Commander, Changyong Wei, Aditi Sharma et al. · Nature Communications · 2020 · 104 citations · Full text

Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax

Richa Bajpai, Shannon M. Matulis, Changyong Wei et al. · Oncogene · 2015 · 98 citations · Full text

Hematological Malignancy, Glutamine Metabolism, Medicine +10

Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma

Richa Bajpai, Aditi Sharma, Abhinav Achreja et al. · Nature Communications · 2020 · 95 citations · Full text

In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy

Rama K. Mishra, Changyong Wei, Richard C. Hresko et al. · Journal of Biological Chemistry · 2015 · 67 citations · Full text

Molecular Docking, Cancer Therapy, Silico Modeling-based Identification +9